Exploring Pharmacogenetic Testing for Hypertension Management in China

作     者：Zhenping Zhao Maigeng Zhou 

作者机构：National Center for Chronic and Noncommunicable Disease Control and PreventionChinese Center for Disease Control and PreventionBeijingChina 

出 版 物：《China CDC weekly》 (中国疾病预防控制中心周报（英文）)

年 卷 期：2023年第5卷第35期

页      面：785-787页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：mortality cardiac alone 

摘      要：Hypertension,or high blood pressure,is a predominant precursor of premature mortality,affecting an estimated 270 million people in China alone,and is also a major global health concern(1).Hence,effective management of hypertension is vital for averting severe adverse cardiac or cerebrovascular incidents,decreasing early mortality rates,and curtailing disability.